Updated Jul 16, 2026
Williams Donald Allen has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $18K.

| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-13 | PALI | PALISADE BIO, INC. | M — Option exercise | 60.7K | — | |
| 2026-06-13 | PALI | PALISADE BIO, INC. | A — Grant or award | 1.50M | — | |
| 2026-01-21 | PALI | PALISADE BIO, INC. | P — Open-market purchase | 5.0K | $1.67 | $8K |
| 2026-01-14 | PALI | PALISADE BIO, INC. | P — Open-market purchase | 5.0K | $1.88 | $9K |
| 2024-11-22 | PALI | PALISADE BIO, INC. | M — Option exercise | 388 | $0.00 |
Williams Donald Allen is a corporate insider — currently tracked as Director of PALISADE BIO, INC. (PALI). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 2 open-market purchases ($18K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Williams Donald Allen profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.